Meet the Team: Dr. Ehsan Malek

Ehsan Malek, MD, joined Roswell Park Comprehensive Cancer Center last fall after spending the past 10 years specializing in multiple myeloma and other plasma cell disorders. Dr. Malek completed his residency in internal medicine at the University of Utah and his fellowship in hematology oncology at the University of Cincinnati.

As the Director of the Multiple Myeloma Translational Research Program at Roswell Park, Dr. Malek brings with him a passion for finding new and innovative treatments for this disease and other plasma cell disorders. His research efforts include minimal residual disease testing and developing pioneering approaches for patients facing high-risk conditions.

“My mission is to understand the mechanism of resistance in CAR T-cell therapies and how we can find new targets to improve patient outcomes by prolonging their survival,” he says. “CAR T-cell therapy has been a paradigm shift for myeloma in the past 10 years.”

Created by

Roswell Park Comprehensive Cancer Center

Related Presenters

Ehsan Malek, MD

Ehsan Malek, MD

Medical Oncology

Specializing In: Plasma Cell Disorders Monoclonal Gammopathy of Undetermined Significance (MGUS) Smoldering Myeloma Amyloidosis Bone Marrow Transplantation Stem Cell Transplantation Immunotherapy

View full profile